Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Chill Yee MD
Chill C. Yee MD Advisory Board
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
Robert Bonakdar MD, FAAFP, FACN
Robert Bonakdar MD, FAAFP, FACN Advisory Board
See All Experts
story of the week
Published in Primary Care and
2 other channels

Journal Scan / Research · March 05, 2020

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets for Newly Diagnosed Atrial Fibrillation

JAMA Network Open

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Michael Kroll MD

Peter Lin MD, CCFP

JAMA Network Open
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
JAMA Netw Open 2020 Feb 05;3(2)e200107, KAA Fox, P Velentgas, AJ Camm, JP Bassand, DA Fitzmaurice, BJ Gersh, SZ Goldhaber, S Goto, S Haas, F Misselwitz, KS Pieper, AGG Turpie, FWA Verheugt, E Dabrowski, K Luo, L Gibbs, AK Kakkar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated